Home Diagnostics to Report Third Quarter 2009 Financial Results on November 5, 2009
19 Octubre 2009 - 3:30PM
Business Wire
Home Diagnostics, Inc. (NASDAQ: HDIX), a leading manufacturer
and marketer of diabetes testing supplies, today announced details
relating to its third quarter 2009 earnings announcement, which
will take place before the market opens on Thursday, November 5,
2009.
Home Diagnostics will hold a conference call on Thursday,
November 5, 2009 at 8:30 a.m. ET to discuss the results. The
dial-in numbers are 1-877-407-0789 for domestic callers and
1-201-689-8562 for international callers. A live Web cast of the
conference call will be available online from the investor
relations page of the Company’s corporate Web site at
www.homediagnostics.com.
After the live Web cast, the call will remain available on the
Home Diagnostics Web site, www.homediagnostics.com, through
December 5, 2009. In addition, a telephonic replay of the call will
be available until November 12, 2009. The replay dial-in numbers
are 1-877-660-6853 for domestic callers and 1-201-612-7415 for
international callers. Please use account number 3055 and
conference ID number 334965.
About Home Diagnostics, Inc.
Based in Fort Lauderdale, Florida, Home Diagnostics, Inc.
(NASDAQ: HDIX) is a leading developer, manufacturer and marketer of
diabetes management products. Home Diagnostics, Inc. offers a
portfolio of high-quality blood glucose monitoring systems that
spans the spectrum of features and benefits to help every person
with diabetes better monitor and manage their disease. The Home
Diagnostics, Inc. product line includes TRUE2go™, TRUEresult®,
TRUEtrack®, TRUEbalance™, Sidekick®, TRUEread® and Prestige IQ®
blood glucose monitoring systems. The products are available in
more than 45,000 pharmacies throughout the U.S. Home Diagnostics is
the exclusive co-brand supplier of blood glucose monitoring systems
for leading pharmacies including CVS, Rite Aid and Walgreens, as
well as distributors such as AmerisourceBergen, Cardinal Health,
McKesson, Invacare and Liberty Medical. Home Diagnostics, Inc. was
named one of Forbes magazine’s “200 Best Small Companies” in 2008,
and in 2009 received several recognitions for the company’s TRUE2go
blood glucose meter, including a Medical Design Excellence Award
(MDEA) and a Gold Award in the Medical/Test Equipment category as
part of appliance DESIGN Magazine’s 22nd Annual Excellence in
Design (EID) Awards Competition. For more information please visit
www.homediagnostics.com.
TRUE2go, TRUEresult, TRUEbalance, TRUEtrack, Sidekick, TRUEread,
Prestige IQ, and TRUEtest are trademarks of Home Diagnostics, Inc.
All other trademarks are property of their respective owners.
[HDIX-F]
Home Diagnostics (MM) (NASDAQ:HDIX)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Home Diagnostics (MM) (NASDAQ:HDIX)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024